2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Tuesday, September 24, 2019

1:45pm-3:15pm: Is there evidence of bradykinesia in patients with Essential Tremor?

D. Colella, M. Bologna, G. Paparella, A. Cannavacciuolo, S. Pietracupa, A. Guerra, A. Berardelli (Rome, Italy)

Tremor · Les Muses Terrace, Level 3

1:45pm-3:15pm: Is VIM-DBS in ET-plus patients as effective as in ET patients?

J. Steffen, J. Petry-Schmelzer, T. Dembek, J. Becker, G. Fink, V. Visser-Vandewalle, M. Barbe (Cologne, Germany)

Tremor · Les Muses Terrace, Level 3

1:45pm-3:15pm: K0706, A Potent Orally Bioavailable Brain-Penetrating Selective Inhibitor of cABL Protein Tyrosine Kinase, Exhibits Neuroprotective Activity in Preclinical Models of Parkinson’s Disease

S. Mandhane, D. Soni, K. Jani, P. Sengupta, A. Patel, R. Bambal, V. Ramanathan, Y. Zala, N. Dharmadhikari, C. Rao, A. Raghavan, N. Damle (Vadodara, India)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Kinematic Analysis of Facial, Upper and Lower Limb Bradkinesia in Parkinson’s Disease

A. Cannavacciuolo, M. Bologna, A. Formica, D. Colella, G. Paparella, A. Guerra, A. Berardelli (Rome, Italy)

Neurophysiology · Les Muses Terrace, Level 3

1:45pm-3:15pm: Language disorders in Progressive Supranuclear Palsy: an underestimated condition?

E. Del Prete, L. Tommasini, D. Frosini, S. Mazzucchi, C. Pagni, U. Bonuccelli, R. Ceravolo (Pisa, Italy)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Left STN DBS And Right CZI DBS In A Patient With Tremor-Predominant Parkinson’s Disease

T. Ali, D. Ginjupally, G. Quintero, C. van Horne, Z. Guduru (Lexington, KY, USA)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Levodopa Induced dyskinesia in patients with Parkinson’s disease and polymorphisms gene DRD3 dopamine receptor

I. Zhukova, N. Zhukova, E. Kolupaeva, S. Ivanova, M. Nikitina, O. Izhboldina, I. Mironova (Tomsk, Russian Federation)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Levodopa response in later stages of Parkinson’s disease: a case-control study

M. Fabbri, M. Coelho, D. Abreu, L. Guedes, M. Rosa, A. Antonini, J. Ferreira (Lisbon, Portugal)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Levodopa-carbidopa intestinal gel infusion: a video analysis of long-term effect on gait and posture

C. Pongmala, M. Fabbri, CA. Artusi, M. Zibetti, L. Lopiano (Turin, Italy)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Limitations of Curcumin as a Therapeutic Agent in Rotenone Induced Dopaminergic Neurodegeneration: Insights from Drosophila Model of Parkinson’s Disease

M. Ayajuddin, SC. Yenisetti (Zunheboto, India)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3